相关实验视频

Updated: Sep 15, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

紧密表达决定了质母细胞瘤中髓状细胞的免疫抑制重编程

Mohammad Asad¹, Julio Inocencio¹, Stefan Mitrasinovic¹

¹Department of Neurological Surgery, Albert Einstein College of Medicine/Montefiore Medical Center; Bronx, NY, 10461, USA.

bioRxiv : the preprint server for biology

|July 14, 2025

概括

质母细胞瘤 (GBM) 免疫疗法面临来自免疫抑制的挑战. 这项研究揭示了TIGIT在髓状细胞上驱动这种抑制,其抑制恢复T细胞功能.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

质母细胞瘤 (GBM) 是一种具有高复发率的侵袭性脑癌.
目前的免疫疗法在GBM中表现出有限的疗效,原因是瘤诱导的免疫抑制.
瘤衍生的细胞外囊泡 (EVs) 和免疫抑制性髓状细胞是GBM免疫逃避的关键贡献者.

研究的目的:

研究GBM微环境中的髓状细胞中TIGIT表达的作用.
探索GBM衍生的EVs对髓状细胞极化和TIGIT表达的影响.
确定针对TIGIT是否可以恢复GBM的抗瘤免疫反应.

主要方法:

来自GBM患者样本的髓状细胞中TIGIT表达的分析.
用GBM衍生的EVs对健康单细胞进行调节,以评估TIGIT诱导.
在骨髓细胞中TIGIT的遗传淘汰,以评估对免疫抑制和T细胞功能的影响.
研究TIGIT和NLRP3炎症酶激活之间的相互作用.

主要成果:

在GBM微环境中,在髓状细胞种群中观察到广泛的TIGIT表达.
来自GBM的EVs在健康单细胞中诱导了TIGIT表达.
TIGIT Knockdown 降低了髓状细胞免疫抑制偏振,并改善了T细胞功能.
TIGIT和NLRP3表现出共同局部,TIGIT的淘汰揭露了NLRP3的炎症活性.

结论:

在GBM微环境中,TIGIT是髓状细胞驱动免疫抑制的关键调解者.
准TIGIT是克服GBM免疫逃避的潜在策略.
调节髓状细胞免疫调节蛋白,如TIGIT和NLRP3,可以恢复抗GBM的免疫反应.

关键词:

在NLRP3中,NLRP3是NLRP3中的一个.这是一个紧张的紧张.细胞外囊泡中的细胞外囊泡.质母细胞瘤是什么免疫疗法免疫疗法骨髓状细胞细胞是什么?

更多相关视频

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.